Office of the Assistant Secretary for Preparedness and Response. (2021). Veklury (Remdesivir). (Added 1/11/2021.) U.S. Department of Health and Human Services.
This page offers a timeline of the approval of Veklury (remdesivir) for treatment of patients with COVID-19 requiring hospitalization and describes how it has been allocated under U.S. government oversight.